Application Scientist: Biosensors (Chinese Speaking / China Projects)

We are looking for an Application Scientist to join our team. In this position, you will be responsible for conducting research, experiments, and validations using the company's phage-biosensor method to detect the early stage of diseases from non-invasive samples (saliva, urine). A key part of this role involves active participation and engagement in our China projects.

Your research topics will mainly cover our phage-biosensor development based on bacteriophage constructs. The work will include developing biosensors towards different disease biomarkers related to cancers, neurological disorders and infectious diseases, performing sample preparation, and analyzing bioassays. The work includes the development of _in-vitro_ evolution processes of phages, and complementary tests using traditional methods with external collaborators. Your duties also consist of documentation, drafting scientific publications, and collaboration with our clinical partners.

What We Expect From You:

• Fluency in Chinese (Mandarin) is a strict requirement for this role.

• Willingness and capability to travel (essential for overseas project collaboration).

• M.Sc in biochemistry, biotechnology, systems biology, or a related discipline.

• Proficiency and interest to work hands-on in laboratory with a genuine interest on capabilities of biotech and phage-biosensors

• Preparation and measurement of clinical samples (such as saliva, urine, blood).

• Good communication skills, a proactive attitude, and problem-solving capabilities are essential to succeed in this position.

• Fluency in English.

It Would Be a Distinct Advantage If You Also Have:

• An understanding of biomarkers and their use in medical diagnoses.

• An interest in different diseases, such as cancers, infectious- or neurological diseases.

• Capability to adopt new methods, technologies, and measurement devices.

• Experience from project management.

AQ Biotech is a Finnish biotech startup revolutionizing early detection of severe diseases through engineered, proprietary phage-biosensors. Our innovative, patented method enables accurate screening of various cancers, infectious and neurological diseases using non-invasive samples like urine and saliva. By leveraging the natural specificity and stability of phages, we provide diagnostic solutions that are significantly more efficient, cost-effective, and accessible than traditional methods.

AQ Biotech has offices in Finland and Hong Kong, alongside joint ventures (JVs) in Nanjing and Chengdu.

We collaborate with world-class research institutions to accelerate new biomarker discovery, aiming to transform healthcare by providing faster, simpler, and widely available life-saving diagnostics. Headquartered in Turku, Finland, we conduct clinical studies and research projects globally, including in Finland, China and Ghana.